Company profile for Eucure Biopharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Eucure Biopharma is a China based innovative biotechnology company with global vision, specializing in developing innovative antibody drugs with independent intellectual property rights. Eucure Biopharma owns a seasoned team with in-depth experience in global clinical development, and is dedicated to providing a comprehensive range of professional services, including clinical medicine, science, clinical operations, regulatory ...
Eucure Biopharma is a China based innovative biotechnology company with global vision, specializing in developing innovative antibody drugs with independent intellectual property rights. Eucure Biopharma owns a seasoned team with in-depth experience in global clinical development, and is dedicated to providing a comprehensive range of professional services, including clinical medicine, science, clinical operations, regulatory registrations, data management, biostatistics, clinical supply chain, CMC, pharmacology & toxicology, clinical safety and pharmacovigilance. Eucure Biopharma has set up offices in Beijing, Shanghai and the US.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
Rm 1202, Building 5, NO.2, South Ronghua Road,BDA,Beijing
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20231016476086/en

BUSINESSWIRE
17 Oct 2023
Chipscreen bags Chinese rights to Biocytogen's Keytruda killer
Chipscreen bags Chinese rights to Biocytogen's Keytruda killer

27 Feb 2023

// Nick Paul Taylor FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/keytruda-killer-chipscreen-bags-chinese-rights-biocytogens-bispecific-antibody

Nick Paul Taylor FIERCE BIOTECH
27 Feb 2023

https://www.clinicaltrialsarena.com/news/fda-biocytogen-solid-tumour-therapy/

CLINICALTRIALSARENA
19 Dec 2022

https://www.clinicaltrialsarena.com/news/fda-biocytogen-solid-tumour-therapy/

CLINICALTRIALSARENA
19 Dec 2022

https://www.businesswire.com/news/home/20221031005342/en

BUSINESSWIRE
31 Oct 2022
Syncromune and Eucure enter antibody licence deal
Syncromune and Eucure enter antibody licence deal

19 Oct 2022

// PHARMACEUTICAL-TECHNOLOGY

https://www.pharmaceutical-technology.com/news/syncromune-eucure-antibody-deal/

PHARMACEUTICAL-TECHNOLOGY
19 Oct 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty